The SNO-NCI Joint Symposium: “Targeting CNS Tumor Metabolism” will foster collaboration in the area of metabolism which will positively influence outcomes for patients with CNS cancers. This is the first conference that focuses on the tumor metabolism and it is expected to be both didactic as well as a collegial learning environment with the goal to enhance partnerships and advance the treatment for patients.  Metabolic investigations for these tumors have been conducted in isolation and the goal of this meeting is to bring together the clinicians with the experts in metabolism in order to increase the utilization of metabolic investigations in the clinical settings.

Participants will gain new understanding in CNS tumor metabolism via the use of state-of-the-art techniques; the interaction between the metabolism and the other -omics such as epigenomics, transcriptomics, as well as the current standard of care; and the challenges in targeting the metabolic signaling pathways.

Scientific Program Co-Chairs

  • Mioara Larion, PhD, National Institutes of Health (NIH Chair)
  • Elizabeth Maher, MD, PhD, UT Southwestern Medical Center (SNO Chair)
Institutional Chairs
  • Mark Gilbert, MD, National Institutes of Health (NIH)
  • Gelareh Zadeh, MD, PhD, University of Toronto (SNO)